Research / BWA / Fundamental state Inspectable configuration
State dimensions Filing 0000908255-26-000062 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
54.52% · OPTIONAL · VALID
Capex intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.58% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.18% · OPTIONAL · VALID
Revenue growth 30th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-2.90% · CORE · VALID
Inventory pressure 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
37.25% · OPTIONAL · VALID
Gross margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
18.98% · CORE · VALID
Operating margin 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
8.66% · CORE · VALID
R&D intensity 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.93% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 18 states Self-history eligible
Dec 31, 2016 0/8 normalized Level 3 Dec 31, 2017 0/9 normalized Level 3 Dec 31, 2017 0/9 normalized Amended as filed Sep 30, 2018 0/8 normalized Level 3 Dec 31, 2018 0/9 normalized Level 3 Mar 31, 2019 0/8 normalized Level 3 Jun 30, 2019 0/8 normalized Level 3 Sep 30, 2019 0/9 normalized Level 3 Dec 31, 2019 0/9 normalized Level 3 Mar 31, 2020 8/9 normalized Level 3 Jun 30, 2020 8/9 normalized Level 3 Sep 30, 2020 8/9 normalized Level 3 Dec 31, 2020 8/9 normalized Level 3 Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Sep 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 105.89%
Current 54.52%
Delta -51.38% Capex Intensity Increased
Previous 2.63%
Current 3.58%
Delta 0.95% Cash Generation Decreased
Previous 16.06%
Current 9.18%
Delta -6.89% Growth Decreased
Previous 0.27%
Current -2.90%
Delta -3.17% Inventory Pressure Increased
Previous 33.77%
Current 37.25%
Delta 3.48% Margin Decreased
Previous 19.76%
Current 18.98%
Delta -0.78% Profitability Decreased
Previous 10.14%
Current 8.66%
Delta -1.48% R And D Intensity Increased
Previous 4.82%
Current 4.93%
Delta 0.11% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2026
Similarity 73%
Compared 8 dimensions
Coverage 100% Growth 15.0 · Margin 35.0 · Profitability 25.0 · Capex Intensity 25.0 · Cash Generation 30.0 · R And D Intensity 10.0 · Inventory Pressure 35.0 · Balance Sheet Leverage 30.0 Sep 30, 2022
Similarity 70%
Compared 8 dimensions
Coverage 100% Growth 41.4 · Margin 16.1 · Profitability 25.0 · Capex Intensity 3.3 · Cash Generation 21.1 · R And D Intensity 47.8 · Inventory Pressure 7.2 · Balance Sheet Leverage 41.7 Sep 30, 2020
Similarity 67%
Compared 7 dimensions
Coverage 88% Margin 15.0 · Profitability 5.0 · Capex Intensity 30.0 · Cash Generation 40.0 · R And D Intensity 20.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 65.0 Jun 30, 2024
Similarity 67%
Compared 7 dimensions
Coverage 88% Growth 25.0 · Margin 20.0 · Profitability 30.0 · Capex Intensity 30.0 · R And D Intensity 50.0 · Inventory Pressure 15.0 · Balance Sheet Leverage 45.0 Jun 30, 2025
Similarity 67%
Compared 7 dimensions
Coverage 88% Growth 25.0 · Margin 50.0 · Profitability 30.0 · Capex Intensity 30.0 · R And D Intensity 20.0 · Inventory Pressure 35.0 · Balance Sheet Leverage 35.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.